{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:58:16Z","timestamp":1791917896911,"version":"4.3.4"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,6,2]],"date-time":"2015-06-02T00:00:00Z","timestamp":1433203200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12865-015-0101-4","type":"journal-article","created":{"date-parts":[[2015,6,2]],"date-time":"2015-06-02T11:22:42Z","timestamp":1433244162000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Characterisation of cell functions and receptors in Chronic Fatigue Syndrome\/Myalgic Encephalomyelitis (CFS\/ME)"],"prefix":"10.1186","volume":"16","author":[{"given":"Sharni Lee","family":"Hardcastle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekua Weba","family":"Brenu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thao","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teilah","family":"Huth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Staines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonya","family":"Marshall-Gradisnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,2]]},"reference":[{"issue":"3","key":"101_CR1","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.jad.2011.09.004","volume":"136","author":"M Maes","year":"2012","unstructured":"Maes M, Twisk FN, Kubera M, Ringel K. Evidence for inflammation and activation of cell-mediated immunity in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS): increased interleukin-1, tumor necrosis factor-\u03b1, PMN-elastase, lysozyme and neopterin. J Affect Disord. 2012;136(3):933\u20139.","journal-title":"J Affect Disord"},{"issue":"1","key":"101_CR2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1006\/clin.1996.0012","volume":"78","author":"A Seide","year":"1996","unstructured":"Seide A, Arolt V, Hunstiger M, Rink L, Behnisch A, Kirchner H. Increased CD56\u2009<\u2009sup\u2009>\u2009+<\/sup\u2009>\u2009natural killer cells and related cytokines in major depression. Clin Immunol Immunopathol. 1996;78(1):83\u20135.","journal-title":"Clin Immunol Immunopathol"},{"issue":"11","key":"101_CR3","doi-asserted-by":"publisher","first-page":"6132","DOI":"10.4049\/jimmunol.167.11.6132","volume":"167","author":"IR Blanca","year":"2001","unstructured":"Blanca IR, Bere EW, Young HA, Ortaldo JR. Human B cell activation by autologous NK cells is regulated by CD40-CD40 ligand interaction: role of memory B cells and CD5+ B cells. J Immunol. 2001;167(11):6132\u20139.","journal-title":"J Immunol"},{"issue":"1","key":"101_CR4","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1365-2567.2008.02887.x","volume":"126","author":"D Schepis","year":"2009","unstructured":"Schepis D, Gunnarsson I, Eloranta ML, Lampa J, Jacobson SH, K\u00e4rre K, et al. Increased proportion of CD56bright natural killer cells in active and inactive systemic lupus erythematosus. Immunology. 2009;126(1):140\u20136.","journal-title":"Immunology"},{"issue":"190","key":"101_CR5","first-page":"2","volume":"5","author":"S Hardcastle","year":"2014","unstructured":"Hardcastle S, Brenu E, Johnston S, Nguyen T, Huth T, Kaur M. Analysis of the relationship between immune dysfunction and symptom severity in patients with Chronic Fatigue Syndrome\/Myalgic Encephalomyelitis (CFS\/ME). J Clin Cell Immunol. 2014;5(190):2.","journal-title":"J Clin Cell Immunol"},{"issue":"8769","key":"101_CR6","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/0140-6736(91)91440-6","volume":"338","author":"A Landay","year":"1991","unstructured":"Landay A, Lennette E, Jessop C, Levy J. Chronic fatigue syndrome: clinical condition associated with immune activation. Lancet. 1991;338(8769):707\u201312.","journal-title":"Lancet"},{"key":"101_CR7","doi-asserted-by":"crossref","unstructured":"Brenu, Hardcastle, Atkinson G, van Driel M, Kreijkamp-Kaspers S, Ashton K, et al.: Natural killer cells in patients with severe chronic fatigue syndrome. Autoimmunity Highlights 2013;4(3):1\u201312.","DOI":"10.1007\/s13317-013-0051-x"},{"issue":"1","key":"101_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1479-5876-8-1","volume":"8","author":"EW Brenu","year":"2010","unstructured":"Brenu EW, Staines DR, Baskurt OK, Ashton KJ, Ramos SB, Christy RM, et al. Immune and hemorheological changes in chronic fatigue syndrome. J Transl Med. 2010;8(1):1.","journal-title":"J Transl Med"},{"key":"101_CR9","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1479-5876-10-88","volume":"10","author":"EW Brenu","year":"2012","unstructured":"Brenu EW, van Driel ML, Staines DR, Ashton KJ, Hardcastle SL, Keane J, et al. Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome\/myalgic encephalomyelitis. J Transl Med. 2012;10:88.","journal-title":"J Transl Med"},{"key":"101_CR10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1479-5876-9-81","volume":"9","author":"EW Brenu","year":"2011","unstructured":"Brenu EW, van Driel ML, Staines DR, Ashton KJ, Ramos SB, Keane J, et al. Immunological abnormalities as potential biomarkers in chronic fatigue syndrome\/myalgic encephalomyelitis. J Transl Med. 2011;9:81.","journal-title":"J Transl Med"},{"issue":"6","key":"101_CR11","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1128\/JCM.28.6.1403-1410.1990","volume":"28","author":"NG Klimas","year":"1990","unstructured":"Klimas NG, Salvato FR, Morgan R, Fletcher MA. Immunologic abnormalities in chronic fatigue syndrome. J Clin Microbiol. 1990;28(6):1403\u201310.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"101_CR12","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1006\/clin.1998.4554","volume":"88","author":"PH Levine","year":"1998","unstructured":"Levine PH, Whiteside TL, Friberg D, Bryant J, Colclough G, Herberman RB. Dysfunction of natural killer activity in a family with chronic fatigue syndrome. Clin Immunol Immunopathol. 1998;88(1):96\u2013104.","journal-title":"Clin Immunol Immunopathol"},{"issue":"Supplement 1","key":"101_CR13","doi-asserted-by":"publisher","first-page":"S157","DOI":"10.1093\/clinids\/18.Supplement_1.S157","volume":"18","author":"EA Ojo-Amaize","year":"1994","unstructured":"Ojo-Amaize EA, Conley EJ, Peter JB. Decreased natural killer cell activity is associated with severity of chronic fatigue immune dysfunction syndrome. Clin Infect Dis. 1994;18(Supplement 1):S157\u20139.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"101_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1207\/S15324826AN0801_7","volume":"8","author":"R Patarca-Montero","year":"2001","unstructured":"Patarca-Montero R, Antoni M, Fletcher MA, Klimas NG. Cytokine and other immunologic markers in chronic fatigue syndrome and their relation to neuropsychological factors. Appl Neuropsychol. 2001;8(1):51\u201364.","journal-title":"Appl Neuropsychol"},{"issue":"Supplement 1","key":"101_CR15","doi-asserted-by":"publisher","first-page":"S136","DOI":"10.1093\/clinids\/18.Supplement_1.S136","volume":"18","author":"E Barker","year":"1994","unstructured":"Barker E, Fujimura SF, Fadem MB, Landay AL, Levy JA. Immunologic abnormalities associated with chronic fatigue syndrome. Clin Infect Dis. 1994;18(Supplement 1):S136\u201341.","journal-title":"Clin Infect Dis"},{"issue":"152.10","key":"101_CR16","first-page":"4172","volume":"4","author":"E Brenu","year":"2013","unstructured":"Brenu E, Johnston S, Hardcastle S, Huth T, Fuller K, Ramos S, et al. Immune abnormalities in patients meeting new diagnostic criteria for chronic fatigue syndrome\/Myalgic Encephalomyelitis. J Mol Biomark Diagn. 2013;4(152.10):4172.","journal-title":"J Mol Biomark Diagn"},{"key":"101_CR17","first-page":"dxt068","volume":"26","author":"EW Brenu","year":"2013","unstructured":"Brenu EW, Huth TK, Hardcastle SL, Fuller K, Kaur M, Johnston S, et al. Role of adaptive and innate immune cells in chronic fatigue syndrome\/myalgic encephalomyelitis. Int Immunol. 2013;26:dxt068.","journal-title":"Int Immunol"},{"key":"101_CR18","doi-asserted-by":"publisher","first-page":"544","DOI":"10.4236\/ijcm.2012.36098","volume":"3","author":"EW Brenu","year":"2012","unstructured":"Brenu EW, van Driel M, Staines DR, Kreijkamp-Kaspers S, Hardcastle SL, Marshall-Gradisnik SM. The effects of influenza vaccination on immune function in patients with Chronic Fatigue Syndrome\/Myalgic Encephalomyelitis. International J Clinical Med. 2012;3:544.","journal-title":"International J Clinical Med"},{"issue":"10","key":"101_CR19","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.4049\/jimmunol.139.10.3306","volume":"139","author":"M Caligiuri","year":"1987","unstructured":"Caligiuri M, Murray C, Buchwald D, Levine H, Cheney P, Peterson D, et al. Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome. J Immunol. 1987;139(10):3306\u201313.","journal-title":"J Immunol"},{"issue":"3","key":"101_CR20","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-2249.2005.02935.x","volume":"142","author":"KJ Maher","year":"2005","unstructured":"Maher KJ, Klimas NG, Fletcher MA. Chronic fatigue syndrome is associated with diminished intracellular perforin. Clin Exp Immunol. 2005;142(3):505\u201311.","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"101_CR21","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1300\/J092v01n01_06","volume":"1","author":"R Patarca","year":"1995","unstructured":"Patarca R, Klimas NG, Garcia MN, Walters MJ, Dombroski D, Pons H, et al. Dysregulated expression of soluble immune mediator receptors in a subset of patients with chronic fatigue syndrome: cross-sectional categorization of patients by immune status. J Chronic Fatigue Syndrome. 1995;1(1):81\u201396.","journal-title":"J Chronic Fatigue Syndrome"},{"issue":"6","key":"101_CR22","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/j.1365-3083.1994.tb03511.x","volume":"40","author":"U Tirelli","year":"1994","unstructured":"Tirelli U, Marotta G, Improta S, Pinto A. Immunological abnormalities in patients with chronic fatigue syndrome. Scand J Immunol. 1994;40(6):601\u20138.","journal-title":"Scand J Immunol"},{"issue":"3","key":"101_CR23","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1006\/clin.1993.1178","volume":"69","author":"T Aoki","year":"1993","unstructured":"Aoki T, Miyakoshi H, Usuda Y, Herberman RB. Low NK syndrome and its relationship to chronic fatigue syndrome. Clin Immunol Immunopathol. 1993;69(3):253\u201365.","journal-title":"Clin Immunol Immunopathol"},{"issue":"223","key":"101_CR24","first-page":"2","volume":"5","author":"T Huth","year":"2014","unstructured":"Huth T, Brenu E, Nguyen T, Hardcastle S, Johnston S. Characterization of natural killer cell phenotypes in chronic fatigue Syndrome\/Myalgic Encephalomyelitis. J Clin Cell Immunol. 2014;5(223):2.","journal-title":"J Clin Cell Immunol"},{"issue":"2","key":"101_CR25","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.jad.2012.03.037","volume":"141","author":"EW Brenu","year":"2012","unstructured":"Brenu EW, Ashton KJ, van Driel M, Staines DR, Peterson D, Atkinson GM, et al. Cytotoxic lymphocyte microRNAs as prospective biomarkers for chronic fatigue syndrome\/myalgic encephalomyelitis. J Affect Disord. 2012;141(2):261\u20139.","journal-title":"J Affect Disord"},{"issue":"9\u201310","key":"101_CR26","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2119\/2007-00059.Saiki","volume":"14","author":"T Saiki","year":"2008","unstructured":"Saiki T, Kawai T, Morita K, Ohta M, Saito T, Rokutan K, et al. Identification of marker genes for differential diagnosis of chronic fatigue syndrome. Mol Med. 2008;14(9\u201310):599.","journal-title":"Mol Med"},{"issue":"1","key":"101_CR27","first-page":"53","volume":"5","author":"JN Baraniuk","year":"2013","unstructured":"Baraniuk JN, Adewuyi O, Merck SJ, Ali M, Ravindran MK, Timbol CR, et al. A Chronic Fatigue Syndrome (CFS) severity score based on case designation criteria. Am J Transl Res. 2013;5(1):53\u201368.","journal-title":"Am J Transl Res"},{"issue":"4","key":"101_CR28","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1365-2796.2011.02428.x","volume":"270","author":"BM Carruthers","year":"2011","unstructured":"Carruthers BM, van de Sande MI, De Meirleir KL, Klimas NG, Broderick G, Mitchell T, et al. Myalgic encephalomyelitis: international consensus criteria. J Intern Med. 2011;270(4):327\u201338.","journal-title":"J Intern Med"},{"issue":"12","key":"101_CR29","doi-asserted-by":"publisher","first-page":"953","DOI":"10.7326\/0003-4819-121-12-199412150-00009","volume":"121","author":"K Fukuda","year":"1994","unstructured":"Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med. 1994;121(12):953\u20139.","journal-title":"Ann Intern Med"},{"key":"101_CR30","doi-asserted-by":"publisher","first-page":"20","DOI":"10.2174\/1874196700902010020","volume":"2","author":"M Zaturenskaya","year":"2009","unstructured":"Zaturenskaya M, Jason LA, Torres-Harding S, Tryon WW. Subgrouping in chronic fatigue syndrome based on actigraphy and illness severity. Open Biology J. 2009;2:20\u20136.","journal-title":"Open Biology J"},{"issue":"1","key":"101_CR31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11065-005-3588-2","volume":"15","author":"LA Jason","year":"2005","unstructured":"Jason LA, Corradi K, Torres-Harding S, Taylor RR, King C. Chronic fatigue syndrome: the need for subtypes. Neuropsychol Rev. 2005;15(1):29\u201358.","journal-title":"Neuropsychol Rev"},{"issue":"1","key":"101_CR32","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.psychres.2010.02.010","volume":"177","author":"JF Wiborg","year":"2010","unstructured":"Wiborg JF, van der Werf S, Prins JB, Bleijenberg G. Being homebound with chronic fatigue syndrome: a multidimensional comparison with outpatients. Psychiatry Res. 2010;177(1):246\u20139.","journal-title":"Psychiatry Res"},{"issue":"3","key":"101_CR33","doi-asserted-by":"crossref","first-page":"122","DOI":"10.5694\/j.1326-5377.1989.tb139594.x","volume":"151","author":"AR Lloyd","year":"1989","unstructured":"Lloyd AR, Wakefield D, Boughton C, Dwyer J. Immunological abnormalities in the chronic fatigue syndrome. Med J Aust. 1989;151(3):122.","journal-title":"Med J Aust"},{"issue":"1","key":"101_CR34","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bbi.2011.06.016","volume":"26","author":"A Bansal","year":"2012","unstructured":"Bansal A, Bradley A, Bishop K, Kiani-Alikhan S, Ford B. Chronic fatigue syndrome, the immune system and viral infection. Brain Behav Immun. 2012;26(1):24\u201331.","journal-title":"Brain Behav Immun"},{"issue":"10","key":"101_CR35","doi-asserted-by":"publisher","first-page":"e26358","DOI":"10.1371\/journal.pone.0026358","volume":"6","author":"\u00d8 Fluge","year":"2011","unstructured":"Fluge \u00d8, Bruland O, Risa K, Storstein A, Kristoffersen EK, Sapkota D, et al. Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study. PLoS One. 2011;6(10):e26358.","journal-title":"PLoS One"},{"issue":"8","key":"101_CR36","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.bbi.2012.06.006","volume":"26","author":"NG Klimas","year":"2012","unstructured":"Klimas NG, Broderick G, Fletcher MA. Biomarkers for chronic fatigue. Brain Behav Immun. 2012;26(8):1202\u201310.","journal-title":"Brain Behav Immun"},{"issue":"1","key":"101_CR37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/ni0103-19","volume":"4","author":"SP Sidorenko","year":"2003","unstructured":"Sidorenko SP, Clark EA. The dual-function CD150 receptor subfamily: the viral attraction. Nat Immunol. 2003;4(1):19\u201324.","journal-title":"Nat Immunol"},{"issue":"1","key":"101_CR38","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/83130","volume":"2","author":"LL Lanier","year":"2001","unstructured":"Lanier LL. On guard\u2014activating NK cell receptors. Nat Immunol. 2001;2(1):23\u20137.","journal-title":"Nat Immunol"},{"issue":"5","key":"101_CR39","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/s002510100337","volume":"53","author":"N Wang","year":"2001","unstructured":"Wang N, Morra M, Wu C, Gullo C, Howie D, Coyle T, et al. CD150 is a member of a family of genes that encode glycoproteins on the surface of hematopoietic cells. Immunogenetics. 2001;53(5):382\u201394.","journal-title":"Immunogenetics"},{"issue":"1","key":"101_CR40","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1600-065X.2006.00453.x","volume":"214","author":"A Veillette","year":"2006","unstructured":"Veillette A. NK cell regulation by SLAM family receptors and SAP\u2010related adapters. Immunol Rev. 2006;214(1):22\u201334.","journal-title":"Immunol Rev"},{"issue":"1","key":"101_CR41","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1034\/j.1600-065X.2001.1810117.x","volume":"181","author":"R Biassoni","year":"2001","unstructured":"Biassoni R, Cantoni C, Pende D, Sivori S, Parolini S, Vitale M, et al. Human natural killer cell receptors and co\u2010receptors. Immunol Rev. 2001;181(1):203\u201314.","journal-title":"Immunol Rev"},{"issue":"4","key":"101_CR42","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1365-2567.2008.03027.x","volume":"126","author":"A Poli","year":"2009","unstructured":"Poli A, Michel T, Th\u00e9r\u00e9sine M, Andr\u00e8s E, Hentges F, Zimmer J. CD56bright natural killer (NK) cells: an important NK cell subset. Immunology. 2009;126(4):458\u201365.","journal-title":"Immunology"},{"issue":"4","key":"101_CR43","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.bbi.2010.01.002","volume":"24","author":"LH Anane","year":"2010","unstructured":"Anane LH, Edwards KM, Burns VE, Zanten JJ, Drayson MT, Bosch JA. Phenotypic characterization of \u03b3\u03b4 T cells mobilized in response to acute psychological stress. Brain Behav Immun. 2010;24(4):608\u201314.","journal-title":"Brain Behav Immun"},{"key":"101_CR44","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","volume":"22","author":"F Sallusto","year":"2004","unstructured":"Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol. 2004;22:745\u201363.","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"101_CR45","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nri3567","volume":"14","author":"DL Farber","year":"2014","unstructured":"Farber DL, Yudanin NA, Restifo NP. Human memory T cells: generation, compartmentalization and homeostasis. Nat Rev Immunol. 2014;14(1):24\u201335.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"101_CR46","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s11357-009-9100-9","volume":"31","author":"SM Henson","year":"2009","unstructured":"Henson SM, Akbar AN. KLRG1\u2014more than a marker for T cell senescence. Age. 2009;31(4):285\u201391.","journal-title":"Age"},{"issue":"1","key":"101_CR47","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/ni.1679","volume":"10","author":"SD Blackburn","year":"2008","unstructured":"Blackburn SD, Shin H, Haining WN, Zou T, Workman CJ, Polley A, et al. Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat Immunol. 2008;10(1):29\u201337.","journal-title":"Nat Immunol"},{"key":"101_CR48","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/1479-5876-11-68","volume":"11","author":"M Curriu","year":"2013","unstructured":"Curriu M, Carrillo J, Massanella M, Rigau J, Alegre J, Puig J, et al. Screening NK-B-and T-cell phenotype and function in patients suffering from Chronic Fatigue Syndrome. J Transl Med. 2013;11:68.","journal-title":"J Transl Med"},{"issue":"7","key":"101_CR49","doi-asserted-by":"publisher","first-page":"4402","DOI":"10.4049\/jimmunol.178.7.4402","volume":"178","author":"E Estefan\u00eda","year":"2007","unstructured":"Estefan\u00eda E, Flores R, G\u00f3mez-Lozano N, Aguilar H, L\u00f3pez-Botet M, Vilches C. Human KIR2DL5 is an inhibitory receptor expressed on the surface of NK and T lymphocyte subsets. J Immunol. 2007;178(7):4402\u201310.","journal-title":"J Immunol"},{"key":"101_CR50","doi-asserted-by":"crossref","unstructured":"Cisneros E, Moraru M, G\u00f3mez-Lozano N, L\u00f3pez-Botet M, Vilches C. KIR2DL5: an orphan inhibitory receptor displaying complex patterns of polymorphism and expression. Front Immunol. 2012;3.","DOI":"10.3389\/fimmu.2012.00289"},{"issue":"11","key":"101_CR51","doi-asserted-by":"publisher","first-page":"5797","DOI":"10.4049\/jimmunol.164.11.5797","volume":"164","author":"C Vilches","year":"2000","unstructured":"Vilches C, Rajalingam R, Uhrberg M, Gardiner CM, Young NT, Parham P. KIR2DL5, a novel killer-cell receptor with a D0-D2 configuration of Ig-like domains. J Immunol. 2000;164(11):5797\u2013804.","journal-title":"J Immunol"},{"issue":"10","key":"101_CR52","doi-asserted-by":"publisher","first-page":"6073","DOI":"10.4049\/jimmunol.178.10.6073","volume":"178","author":"MA Hurchla","year":"2007","unstructured":"Hurchla MA, Sedy JR, Murphy KM. Unexpected role of B and T lymphocyte attenuator in sustaining cell survival during chronic allostimulation. J Immunol. 2007;178(10):6073\u201382.","journal-title":"J Immunol"},{"issue":"2","key":"101_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0031959","volume":"7","author":"N Nielsen","year":"2012","unstructured":"Nielsen N, \u00d8dum N, Urs\u00f8 B, Lanier LL, Spee P. Cytotoxicity of CD56bright NK cells towards autologous activated CD4+ T cells is mediated through NKG2D, LFA-1 and TRAIL and dampened via CD94\/NKG2A. PLoS One. 2012;7(2), e31959.","journal-title":"PLoS One"},{"issue":"1","key":"101_CR54","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1600-065X.2006.00457.x","volume":"214","author":"YT Bryceson","year":"2006","unstructured":"Bryceson YT, March ME, Ljunggren HG, Long EO. Activation, coactivation, and costimulation of resting human natural killer cells. Immunol Rev. 2006;214(1):73\u201391.","journal-title":"Immunol Rev"},{"issue":"2","key":"101_CR55","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1006\/bcmd.2002.0506","volume":"28","author":"M Lima","year":"2002","unstructured":"Lima M, Almeida J, dos Anjos TM, Queir\u00f3s ML, Justi\u00e7a B, Orf\u00e3o A. The \u201c< i\u2009>\u2009ex Vivo<\/i>\u201d Patterns of CD2\/CD7, CD57\/CD11c, CD38\/CD11b, CD45RA\/CD45RO, and CD11a\/HLA-DR Expression Identify Acute\/Early and Chronic\/Late NK-Cell Activation States. Blood Cell Mol Dis. 2002;28(2):181\u201390.","journal-title":"Blood Cell Mol Dis"},{"issue":"3","key":"101_CR56","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/nri1571","volume":"5","author":"R Glaser","year":"2005","unstructured":"Glaser R, Kiecolt-Glaser JK. Stress-induced immune dysfunction: implications for health. Nat Rev Immunol. 2005;5(3):243\u201351.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"101_CR57","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nri1369","volume":"4","author":"PA Bryant","year":"2004","unstructured":"Bryant PA, Trinder J, Curtis N. Sick and tired: does sleep have a vital role in the immune system? Nat Rev Immunol. 2004;4(6):457\u201367.","journal-title":"Nat Rev Immunol"},{"key":"101_CR58","volume-title":"World Health Organization","author":"TB \u00dcst\u00fcn","year":"2010","unstructured":"\u00dcst\u00fcn TB. Measuring health and disability: Manual for WHO disability assessment schedule WHODAS 2.0. In: World Health Organization. 2010."},{"key":"101_CR59","first-page":"473","volume-title":"Medical care","author":"JE Ware Jr","year":"1992","unstructured":"Ware Jr JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. In: Medical care. 1992. p. 473\u201383."},{"issue":"1","key":"101_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2567.2007.02647.x","volume":"122","author":"CJ Montoya","year":"2007","unstructured":"Montoya CJ, Pollard D, Martinson J, Kumari K, Wasserfall C, Mulder CB, et al. Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell\u2010clonotypic monoclonal antibody, 6B11. Immunology. 2007;122(1):1\u201314.","journal-title":"Immunology"},{"issue":"2","key":"101_CR61","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1177\/1094428112470848","volume":"16","author":"H Aguinis","year":"2013","unstructured":"Aguinis H, Gottfredson RK, Joo H. Best-practice recommendations for defining, identifying, and handling outliers. Organ Res Methods. 2013;16(2):270\u2013301.","journal-title":"Organ Res Methods"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12865-015-0101-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-015-0101-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-015-0101-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-015-0101-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T01:36:30Z","timestamp":1691717790000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcimmunol.biomedcentral.com\/articles\/10.1186\/s12865-015-0101-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,2]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["101"],"URL":"https:\/\/doi.org\/10.1186\/s12865-015-0101-4","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,2]]},"assertion":[{"value":"28 November 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"35"}}